All Newsletters

Brand Institute Partners on the Brand Name Development for 4 Historic FDA Approvals in 2023

As reported in a recent article from PharmaVoice, these Products include the first vaccine for RSV, a new therapy for Alzheimer’s, a full approval for a COVID-19 treatment, and the first oral medication for postpartum depression.

December 7, 2023

Brand Institute is pleased to share our most recent corporate brand naming experience

Brand Institute is pleased to share our most recent corporate brand naming experience

December 5, 2023

Brand Institute is proud to have partnered on 30 FDA-Approved Biosimilar brand names

About Brand Institute and our wholly owned regulatory subsidiary, Drug Safety Institute Brand Institute is the global leader in pharmaceutical and healthcare-related name development, with aportfolio of over 4,000 marketed healthcare brand names, 1,300 USAN/INN nonproprietary names for1,200 clients.

August 8, 2023

Brand Institute is proud to have partnered on 85% of FDA approved pharmaceutical brand names in 2022!

Select 2022 FDA CDER Brand Name Approvals Select 2022 FDA CDER Brand Name Approvals

January 12, 2023

Brand Institute Attends the 2022 HBSHAA Annual Conference in Boston, MA

Brand Institute, a Gold Sponsor of the Harvard Business School Healthcare Alumni Association (HBSHAA)...

August 22, 2022

Brand Institute is proud to have partnered with 390 healthcare companies on 884 nonproprietary (USAN/INN) names, including 41 pain & inflammation USAN/INN names!

Highlighted by the pain & inflammation nonproprietary USAN/INN name approvals listed below:

December 8, 2020

Brand Institute is proud to have partnered on the brand name development for AveXis' Zolgensma®

The first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)

August 1, 2020

Brand Institute is proud to sponsor Emmo Jr. Fittipaldi as he takes the checkred Flag

Winning the IAME Junior Group in the 2020 GoPro Motorplex Karting Challenge!

June 1, 2020

Brickell Magazine Publishes Feature Story About Brand Institute’s Sponsorship of Emmo Jr. Fittipaldi!

One of racing’s most legendary names joined forces with one of the world’s most prolific branding agencies....

April 8, 2020

Brand Institute is Leading the Way in Digital Health and Digital Therapeutics Branding!

Digital Health and Digital Therapeutics are becoming increasingly relevant and in-demand considering the COVID-19...

April 8, 2020

Brand Institute is proud to have partnered on the following diagnostic medical devices!

Including ID NOW, Abbott’s molecular diagnostic platform...

April 1, 2020

Brand Institute sponsorship of Emmo Jr. Fittipaldi featured in key biscayne magazine!

The story of how one of racing’s most iconic names and one of the world’s most prolific branding agencies came together at Ocean Club....

April 1, 2020

We would like to extend our best wishes for you and your family during these challenging times

WE ARE PROUD TO HAVE PARTNERED ON 78% OF THE MOST RECENTLY APPROVED...

March 1, 2020

We would like to extend our best wishes for you and your family during these challenging times

WE ARE PROUD TO HAVE PARTNERED ON THE FOLLOWING BRAND NAMES...

March 1, 2020

Brand Institute participates in luncheon round table with Brazilian President, Jair Bolsonaro

On Sunday, March 8th, 2020, Brand Institute Chairman & CEO, James L. Dettore, joined Brazilian President, Jair Bolsonaro)...

March 1, 2020

CONGRATULATIONS ON YOUR RECENT FDA APPROVAL

We are proud to have partnered with you and hope to work on your next naming project!...

March 1, 2020

Brand Institute Partners on the Following ANVISA Brand Name Approvals

Brand Institute is proud to sponsor Emmo Jr. Fittipaldi...

March 1, 2020

CONSUMER HEALTHCARE PRODUCTS

SELECT NAMING EXPERIENCE, click to view snapshop of consumer healthcare products...

February 1, 2020

Brand Institute is Proud to Name Over 75% of Drugs Approved Worldwide

Below is a snapshot of select 2019 FDA brand name approval experience...

January 1, 2020

DRUG SAFETY INSTITUTE INVITED BY ABIMIP TO ANVISA!

On March, 21st, 2019, Brand Institute (BI) and subsidiary Drug Safety Institute (DSI), ...

June 21, 2019

Brand Institute is proud to have partnered on the following FDA-approved brand names for 2019!

Brand Institute naming partnerships include any single service or combination of services...

June 21, 2019

We are Proud to Have Partnered on 55 New INN Name Approvals!

Ms. Fuerst is President of Drug Safety Institute's Nonproprietary (USAN/INN) Names Division.

October 21, 2019

Brand Institute is proud to have partnered on 81% of FDA approved biosimilar brand names for 2019!

Click to view a snapshot of select 2019 FDA brand name approval experience.

November 21, 2019

BRAND INSTITUTE ATTENDS 140th ANNUAL INTA MEETING.

At the beginning of this year’s #FierceMadness drug name tournament, …

June 20, 2018

Brand Institute Team Members participate in the Mercedes-Benz Corporate Run

The Mercedes-Benz Corporate Run is one of the largest 5k races in the nation …

May 20, 2018

GOVERNMENT NAMING OFFICIALS JOIN BI/DSI

Mr. Bridges joined DSI – Rockville in May 2018 as Global President. Prior to joining …

May 12, 2018

CONGRATULATIONS TO BIOMARIN FOR WINNING FIERCEBIOTECH’S 2018

For the second time in a row, a BioMarin drug brand name has won FierceBiotech’s …

April 20, 2018

DSI UPDATES GLOBAL NAME SAFETY RESEARCH MODEL

Drug Safety Institute (DSI) has revised our name safety research methodology based on newly discovered review …

February 20, 2018

DSI offers new service for HUMAN FACTORS STUDIES

In accordance with FDA’s February 2016 Draft Guidance titled “Human Factors Studies and Related Clinical Study Considerations in …

January 20, 2018